This is a partial list of the current clinical trials for new medications. If you are interested in finding more information, we’ve provided links to each study. You can also check the NIH National Library of Medicine clinicaltrials.gov to search for a more complete list and the status of each study.
- Following FDA approval Xeris Pharma(formerly Strongbridge) announced Recorlev® (levoketoconazole) Is now commercially available for the treatment of endogenous Cushing’s Syndrome. Read more here…
- Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study. To learn more about the trial and see if you qualify. Read more here…
- Camurus AB announced two clinical trials for an octreotide subcutaneous depot to treat acromegaly. Read more he…
- From Recordati Rare Diseases more news on its new drug for Cushing’s ISTURISA. Read more…
- Corcept Therapeutics launches website supporting Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome. Click here to learn more and see if you qualify.
- Ionis Ph is currently enrolling acromegaly patients – more info at patients@ionisph.com
Please get in touch with us if you would like us to add a study to this list, and always check with your doctor for advice.
© 2022, Pituitary World News. All rights reserved.